Consistently, lower ITGA3 expression has been correlated with metastasis and poor prognosis in CRC patients, and in many cases, metastatic tumors had lower α3 expression levels than their corresponding primary tumors [38,39]. Here, ITGA3 is linked to metastatic neoplasm.